Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Atzler

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Cardiovascular Research|May 19, 2022
Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory stateLaura A Bosmans, Claudia M van Tiel, Suzanne A B M Aarts, et al.
European Heart Journal Open|March 27, 2023
Hyperlipidaemia elicits an atypical, T helper 1-like CD4<sup>+</sup> T-cell response: a key role for very low-density lipoproteinBram W van Os, Winnie G Vos, Laura A Bosmans, et al.
Nature Communications|June 19, 2021
Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular diseaseMichael Lacy, Christina Bürger, Annelie Shami, et al.
European Heart Journal|November 20, 2018
Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage deathTom T P Seijkens, Kikkie Poels, Svenja Meiler, et al.
Nature Cardiovascular Research|July 24, 2024
Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosisYvonne Döring, Emiel P C van der Vorst, Yi Yan, et al.
Journal of the American College of Cardiology|February 7, 2018
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces AtherosclerosisTom T P Seijkens, Claudia M van Tiel, Pascal J H Kusters, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Cardiovascular Research|May 19, 2022
Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory stateLaura A Bosmans, Claudia M van Tiel, Suzanne A B M Aarts, et al.
European Heart Journal Open|March 27, 2023
Hyperlipidaemia elicits an atypical, T helper 1-like CD4<sup>+</sup> T-cell response: a key role for very low-density lipoproteinBram W van Os, Winnie G Vos, Laura A Bosmans, et al.
Nature Communications|June 19, 2021
Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular diseaseMichael Lacy, Christina Bürger, Annelie Shami, et al.
European Heart Journal|November 20, 2018
Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage deathTom T P Seijkens, Kikkie Poels, Svenja Meiler, et al.
Nature Cardiovascular Research|July 24, 2024
Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosisYvonne Döring, Emiel P C van der Vorst, Yi Yan, et al.
Journal of the American College of Cardiology|February 7, 2018
Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces AtherosclerosisTom T P Seijkens, Claudia M van Tiel, Pascal J H Kusters, et al.
Pageof 8